EN-1435
Hospira, Inc., Lake Forest, IL 60045 USA
CA-2323
CA-2324
Atropine SULFATE
Atropine sulfate injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0409-4910
Route of Administration INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Atropine SULFATE (Atropine) Atropine SULFATE 0.1 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE
SODIUM HYDROXIDE
SULFURIC ACID
Packaging
Item Code Package Description
1 NDC:0409-4910-34 1 SYRINGE in 1 CARTON
1 5 mL in 1 SYRINGE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 08/25/2005
Atropine SULFATE
Atropine sulfate injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0409-4911
Route of Administration INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Atropine SULFATE (Atropine) Atropine SULFATE 0.1 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE
SODIUM HYDROXIDE
SULFURIC ACID
Packaging
Item Code Package Description
1 NDC:0409-4911-34 1 SYRINGE in 1 CARTON
1 10 mL in 1 SYRINGE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 10/25/2005 |
